Company Overview and News


Add CVS
to your dashboard

Headline News

Can Walgreens Exceed Analyst Expectations in Fiscal 4Q17?

2017-10-20 marketrealist
Walgreens Boots Alliance (WBA) is slated to release its fiscal 4Q171 results on Wednesday, October 25, 2017. The pharmacy giant is expected to report an increase of $1.21 in earnings per share (or EPS) for 13.1% growth year-over-year (or YoY). WBA’s total sales are expected to reach $29.6 billion, a 4.6% increase over its fiscal 4Q16 sales. (138-0)

You Should Buy Rite Aid Corporation Stock Only If This Happens

2017-10-19 investorplace
Rite Aid Corporation (NYSE:RAD) investors certainly haven’t been faced with a shortage of things to chew on of late. Between a (greatly) scaled-back deal to sell some of its stores to rival Walgreens Boots Alliance Inc (NASDAQ:WBA) and reports that Amazon.com, Inc. (NASDAQ:AMZN) was mulling an entry into the prescription drug business, RAD stock news headlines have been plentiful… and mostly bearish. (227-0)

No Pharmacy Has the Cure to Amazon Stock Price -- Yet | InvestorPlace

2017-10-19 investorplace
Amazon.com, Inc. (NASDAQ:AMZN) continues its rapid movement into a bunch of new industries in 2017. After shocking the grocery world with the Whole Foods purchase just a couple months ago, Amazon appears set to make another big move. This time the target is drugstores. And that makes things interesting for AMZN stock. (227-2)

PRESS DIGEST- New York Times business news - Oct 19

2017-10-19 reuters
Oct 19 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. (94-0)

Business News Roundup, Oct. 19

2017-10-18 sfgate
An investment industry regulator has ordered Wells Fargo to pay $3.4 million to brokerage customers who lost money buying complicated securities that even Wells Fargo brokers didn’t fully understand. (78-0)

Amazon, Anthem, Congress Put Drug Benefits Firms in Hot Spot - Bloomberg

2017-10-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (97-0)

Dow trades above 23,000-mark as IBM's stock jumps

2017-10-18 in.reuters
NEW YORK (Reuters) - The Dow Jones industrial average rose again above the 23,000 level on Wednesday, driven by a jump in IBM after the computing giant hinted at a return to revenue growth. (9-0)

How Lawyers Protect the Harvey Weinstein in Your Workplace - Bloomberg

2017-10-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (37-0)

Walgreens Investors Need Not Fear Amazon: A Deep Due-Diligence Dive (And Huge Insider Buys)

2017-10-18 seekingalpha
The rumor of Amazon's entry into the space is assumed to have caused the stock's tumble (160-0)

Pharmacy Bears: High On Drugs

2017-10-18 seekingalpha
We recently added CVS to our portfolio as fears of Amazon entering the pharmacy space hit a fever pitch. (159-0)

Anthem Inc (ANTM), CVS Health Corp (CVS) Team Up in Prescription Drugs Deal | InvestorPlace

2017-10-18 investorplace
Anthem Inc (NYSE:ANTM) and CVS Health Corp (NYSE:CVS) are teaming up to create a new pharmacy benefits manager. (43-0)

In the Saga of Rite Aid Corporation, Amazon Plays Godot

2017-10-18 investorplace
Spoiler alert. In the Samuel Beckett play Waiting for Godot, Godot never shows up. In the continuing saga of Rite Aid Corp. (NYSE:RAD), Amazon.Com Inc. (NASDAQ:AMZN) is now playing the part of Godot. (255-0)

10 Blue-Chip Dividend Stocks to Buy for 2018 | InvestorPlace

2017-10-18 investorplace
As we enter the homestretch of 2017, it’s already time to start planning ahead for 2018. And if next year proves to be anything like this year, we should expect the unexpected. I’m a big believer in finding the best dividend stocks to buy — and particularly blue-chip dividend stocks — in virtually any market environment. But not all dividend stocks move in lockstep, and some are clearly better suited for certain environments than others. (397-1)

Anthem Breaks With Express Scripts, Will Start Own Drug Plan - Bloomberg

2017-10-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (48-0)

CORRECTED-UPDATE 2-Health insurer Anthem takes pharmacy business in house, taps CVS to help

2017-10-18 reuters
Oct 18 (Reuters) - Health insurer Anthem Inc will start managing its billions of dollars of patient prescriptions itself in 2020, it said on Wednesday, ending a deal with Express Scripts Holding that had deteriorated into lawsuits over terms. (43-0)

UPDATE 2-Health insurer Anthem takes pharmacy business in house, taps CVS to help

2017-10-18 reuters
(Reuters) - Health insurer Anthem Inc will start managing its billions of dollars of patient prescriptions itself in 2020, it said on Wednesday, ending a deal with Express Scripts Holding that had deteriorated into lawsuits over terms. (43-0)

Anthem Signs Deal With CVS for Services to New Pharmacy-Benefit Manager - WSJ

2017-10-18 wsj
Anthem Inc. said it would launch its own pharmacy-benefit manager, serviced by CVS Health Corp., in 2020 after the conclusion of its current contract with Express Scripts Holding Co. (43-0)

BRIEF-CVS Health signs five-year agreement with Anthem

2017-10-18 reuters
* CVS Health - ‍expects to incur implementation costs related to transition of members; costs expected to be immaterial to 2017 results​ (1-0)

These 2 High-Yield Dividend Growth Stocks May Eventually Be Doomed To Oblivion

2017-10-17 seekingalpha
Cisco and IBM have both badly underperformed the S&P 500 over the past decade, and for good reason. (18-0)

Drug Supply Players Point a Finger Everywhere But Themselves - Bloomberg

2017-10-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (1-0)

Walgreens Pick Up: Sell-Off Offers 40% Upside

2017-10-17 seekingalpha
Rumors around Amazon (NASDAQ:AMZN) entering the pharmaceutical business led to Walgreens' (NASDAQ:WBA) 8% drop off last week and has created a buying opportunity. (227-0)

Profit From The Elephant In The Room

2017-10-17 seekingalpha
When a formerly high-flying stock has been trashed, it pays to figure out “why” before committing new money to that name. (144-0)

Buy The Pullback In Walgreens Boots Alliance

2017-10-16 seekingalpha
The current pullback in Walgreen Boots Alliance's share price offers investors the opportunity to start building a position in a great company. (138-0)

Top Losers in the Consumer Sector: October 9–13, 2017

2017-10-16 marketrealist
Drug companies like CVS Health (CVS) and Walgreens Boots Alliance (WBA) continued to fall last week as speculations continued about Amazon’s (AMZN) entry into the online drug business. On October 6, CNBC reported that Amazon plans to sell prescription drugs online. Walgreens stock fell 7.7%, while CVS stock fell 5.6% last week. (29-0)

Consumer Sector Insights for the Week of October 9–13

2017-10-16 marketrealist
The third quarter earnings season has picked up the pace. The S&P 500 Index (SPY) (SPX-Index) finished the week ending October 13 with slight growth of 0.15%. The consumer staples sector was the top gainer last week—led by a rise in Walmart stock. (32-0)

CUSIP: 126650950